Please login to the form below

Not currently logged in

Takeda expands into Brazil

Takeda, Japan's largest drug company, has announced it is to establish a commercial subsidiary in Brazil

Takeda, Japan's largest drug company, has announced it is to establish a commercial subsidiary in Brazil.

The new operation, which will be based in Sao Paulo, will import and commercialise Takeda products for the Brazilian market.

This latest expansion by the Japanese company is the twelfth in as many months following the establishment of subsidiaries in Belgium, Canada, Denmark, Ireland, Luxembourg, Mexico, Norway, Portugal, Spain, Sweden and Turkey.

"Combined with Takeda's additional recent expansions, this opportunity will drive Takeda's ability to maximise the potential of our pipeline in Brazil," said Alan MacKenzie, executive vice president international operations, Takeda Pharmaceuticals International.

"Brazil is an important country in the Latin American region for Takeda to ensure we are providing our products where patients need them."

With a population of around 196 million people, Brazil is the largest country in Latin America and accounts for more than 40 per cent of pharmaceutical sales in the region. Pharmaceutical sales in the country are forecast to grow by 8.5 per cent each year until 2013.

2nd December 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...